0.00Open0.00Pre Close0 Volume0 Open Interest20.00Strike Price0.00Turnover558.85%IV156.41%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.2855Delta0.0475Gamma9.18Leverage Ratio-0.1242Theta0.0004Rho2.62Eff Leverage0.0043Vega
INmune Bio Stock Discussion
• $SpringWorks Therapeutics(SWTX.US)$ +19.2% (Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase3DeFi Trial )
• $Roivant Sciences(ROIV.US)$ +7.1% (FDA has approved VTAMA (tapinarof) cream)
• $Ocugen(OCGN.US)$ +5.9% (announces that it is diversifying its innovative pipeline by introducing a Phase 3 cell therapy platform technology called Ne?Cart)
• $Skyline(SKY.US)$ +4.4% (In reaction to earnings)
• $NetEase(NTES.US)$ +4.1% (In...
No comment yet